The effect of a GnRH antagonist on endocrine and seminal parameters in stallions.

This study explores the impact of a GnRH antagonist, Antarelix, on the endocrine and semen parameters in horse stallions. The study found that the administration of the antagonist led to a decrease in gonadotropins, testosterone, and estradiol in the stallions, manifested in decreased libido and testicular changes.

Objective of the Research

• The core objective of this investigation was to study the effect of the Gonadotropin-Releasing Hormone (GnRH) antagonist Antarelix on the endocrine and seminal parameters in stallions. The endocrine response to reproduction in stallions remains relatively unexplored, and this research aimed to deepen our understanding of this area.

Methodology

• The study was initiated by treating four pony stallions with the potent GnRH antagonist, Antarelix.
• Following the administration of this substance, the research team examined the libidos, seminal parameters, and hormonal profiles of the stallions, comparing them with those recorded before the administration of the antagonist.

Findings

• The study revealed a decrease in the stallions’ blood plasma concentrations of gonadotropins, testosterone, and estradiol 48 hours post-antagonist administration.
• The suppression of FSH and estradiol was the most consistent finding across the sample. These reduced concentrations persisted for 4 weeks.
• No significant impact on sperm motility, numbers, or morphology was registered as a result of the treatment, but there was a noticeable rise in the number of round spermatogenic cells in the ejaculate as the trial progressed.
• Libido was another area of study, in which researchers assessed the time it took for the stallions to regain an erection following ejaculation in the presence of a mare – recorded as the ‘refractory period’. This time increased significantly after treatment with the antagonist.
• The researchers also found histological evidence of testicular degeneration when the stallions were castrated eight weeks after treatment with the antagonist, indicating fertility complications.

Conclusion

• The study concluded that the use of a GnRH antagonist could serve as a valuable research tool in further studies eager to dissect how changes in circulating hormone concentrations affect stallions.
• Other potential areas of further research include investigating the reversibility of the antagonist’s effects on both libido and testicular changes.